Fonte: Hematology, Transfusion and Cell Therapy. Nome do evento: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FMRP, BIOTECNOLOGIA
Assuntos: BIOMARCADORES, ANEMIA FALCIFORME, HEMATOLOGIA
ABNT
LAMARRE, Yann Ives et al. Leveraging plasma-derived exosomes for biomarker discovery in sickle cell disease: preparation for a large prospective study. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.077. Acesso em: 30 ago. 2024. , 2020APA
Lamarre, Y. I., Aich, A., Islam, M., Scianni, J. M., Pinto, A. C. S., Tavassi, A. M. C., et al. (2020). Leveraging plasma-derived exosomes for biomarker discovery in sickle cell disease: preparation for a large prospective study. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.077NLM
Lamarre YI, Aich A, Islam M, Scianni JM, Pinto ACS, Tavassi AMC, Elion J, Nemer WE, Saha R, Haddad SK, Covas DT. Leveraging plasma-derived exosomes for biomarker discovery in sickle cell disease: preparation for a large prospective study [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S47.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.htct.2020.10.077Vancouver
Lamarre YI, Aich A, Islam M, Scianni JM, Pinto ACS, Tavassi AMC, Elion J, Nemer WE, Saha R, Haddad SK, Covas DT. Leveraging plasma-derived exosomes for biomarker discovery in sickle cell disease: preparation for a large prospective study [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S47.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.htct.2020.10.077